Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: Cancer Prev Res (Phila). 2009 Sep 8;2(9):823–829. doi: 10.1158/1940-6207.CAPR-09-0077

Figure 4. COX-2 expression: Impact on survival in induction trial.

Figure 4

Kaplan-Meier estimator was used to estimate the survival distribution of all patients and to compare the overall survival of patients with high versus low COX-2 expression. A cut-off point of COX-2 expression of 0.856 was used to differentiate between low versus high expressers in the survival analysis.